| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prognostic significance of dyspnea in patients referred for cardiac stress testing.
|
N Engl J Med
|
2005
|
6.27
|
|
2
|
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
|
J Am Coll Cardiol
|
2002
|
4.11
|
|
3
|
Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial.
|
Circulation
|
2011
|
3.63
|
|
4
|
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease.
|
Circulation
|
2002
|
2.97
|
|
5
|
Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography.
|
J Am Coll Cardiol
|
2004
|
2.77
|
|
6
|
Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study.
|
Circulation
|
2008
|
2.77
|
|
7
|
Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?
|
J Nucl Cardiol
|
2012
|
2.48
|
|
8
|
Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis.
|
J Nucl Cardiol
|
2009
|
2.22
|
|
9
|
Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT.
|
J Am Coll Cardiol
|
2003
|
1.97
|
|
10
|
The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality: superiority over 85% of maximal age-predicted heart rate.
|
J Am Coll Cardiol
|
2004
|
1.94
|
|
11
|
Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.
|
JACC Cardiovasc Imaging
|
2009
|
1.93
|
|
12
|
Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT.
|
J Nucl Med
|
2003
|
1.92
|
|
13
|
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
|
Am Heart J
|
2012
|
1.84
|
|
14
|
New technology for noninvasive evaluation of coronary artery disease.
|
Circulation
|
2007
|
1.74
|
|
15
|
Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT.
|
J Nucl Cardiol
|
2010
|
1.71
|
|
16
|
The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium.
|
J Am Coll Cardiol
|
2003
|
1.69
|
|
17
|
Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management.
|
J Am Coll Cardiol
|
2003
|
1.68
|
|
18
|
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
|
Circ Cardiovasc Imaging
|
2013
|
1.58
|
|
19
|
Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients.
|
Eur Heart J
|
2004
|
1.58
|
|
20
|
Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area.
|
JACC Cardiovasc Imaging
|
2008
|
1.55
|
|
21
|
Lack of Survival Benefit Found With Use of Intraaortic Balloon Pump in Extracorporeal Membrane Oxygenation: A Pooled Experience of 1517 Patients.
|
J Invasive Cardiol
|
2015
|
1.52
|
|
22
|
Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction.
|
Circulation
|
2013
|
1.51
|
|
23
|
Prognostic value of myocardial perfusion SPECT versus exercise electrocardiography in patients with ST-segment depression on resting electrocardiography.
|
J Nucl Cardiol
|
2005
|
1.40
|
|
24
|
Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation.
|
J Nucl Cardiol
|
2004
|
1.33
|
|
25
|
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging.
|
J Nucl Cardiol
|
2007
|
1.31
|
|
26
|
Cardiovascular imaging research at the crossroads.
|
JACC Cardiovasc Imaging
|
2010
|
1.27
|
|
27
|
Should PET replace SPECT for evaluating CAD? The end of the beginning.
|
J Nucl Cardiol
|
2006
|
1.24
|
|
28
|
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
|
Arch Intern Med
|
2012
|
1.21
|
|
29
|
Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events.
|
Circulation
|
2011
|
1.15
|
|
30
|
Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease.
|
J Nucl Med
|
2006
|
1.13
|
|
31
|
Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study.
|
Circulation
|
2003
|
1.09
|
|
32
|
Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD.
|
J Nucl Med
|
2004
|
1.09
|
|
33
|
Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction.
|
Circ Cardiovasc Imaging
|
2009
|
1.07
|
|
34
|
Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease.
|
J Nucl Cardiol
|
2009
|
0.99
|
|
35
|
Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) Study.
|
J Am Coll Cardiol
|
2004
|
0.97
|
|
36
|
ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 health policy statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee.
|
J Am Coll Cardiol
|
2014
|
0.96
|
|
37
|
Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease.
|
J Nucl Med
|
2006
|
0.94
|
|
38
|
Are shades of gray prognostically useful in reporting myocardial perfusion single-photon emission computed tomography?
|
Circ Cardiovasc Imaging
|
2009
|
0.93
|
|
39
|
Comparative use of radionuclide stress testing, coronary artery calcium scanning, and noninvasive coronary angiography for diagnostic and prognostic cardiac assessment.
|
Semin Nucl Med
|
2007
|
0.92
|
|
40
|
Cost-effectiveness of coronary computed tomography and cardiac stress imaging in the emergency department: a decision analytic model comparing diagnostic strategies for chest pain in patients at low risk of acute coronary syndromes.
|
JACC Cardiovasc Imaging
|
2011
|
0.89
|
|
41
|
Added value of rest to stress study for recognition of artifacts in perfusion cardiovascular magnetic resonance.
|
J Cardiovasc Magn Reson
|
2007
|
0.88
|
|
42
|
Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction.
|
Am J Cardiol
|
2012
|
0.88
|
|
43
|
Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging.
|
J Nucl Cardiol
|
2006
|
0.87
|
|
44
|
Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization.
|
J Am Coll Cardiol
|
2013
|
0.87
|
|
45
|
Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography.
|
J Am Coll Cardiol
|
2004
|
0.86
|
|
46
|
Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT.
|
J Nucl Cardiol
|
2011
|
0.86
|
|
47
|
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.
|
J Nucl Cardiol
|
2013
|
0.85
|
|
48
|
Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability.
|
Circulation
|
2012
|
0.85
|
|
49
|
Impact of body mass index on cardiac mortality in patients with known or suspected coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography.
|
J Am Coll Cardiol
|
2006
|
0.85
|
|
50
|
Prognostic value of automated vs visual analysis for adenosine stress myocardial perfusion SPECT in patients without prior coronary artery disease: a case-control study.
|
J Nucl Cardiol
|
2011
|
0.84
|
|
51
|
Hybrid PET/CT is greater than the sum of its parts.
|
J Nucl Cardiol
|
2008
|
0.84
|
|
52
|
The significance of transient ischemic dilation in the setting of otherwise normal SPECT radionuclide myocardial perfusion images.
|
J Nucl Cardiol
|
2011
|
0.84
|
|
53
|
Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT.
|
JACC Cardiovasc Imaging
|
2010
|
0.83
|
|
54
|
Integrated cardiac PET-CT for the diagnosis and management of CAD.
|
J Nucl Cardiol
|
2006
|
0.83
|
|
55
|
Clinical benefits of noninvasive testing: coronary computed tomography angiography as a test case.
|
JACC Cardiovasc Imaging
|
2010
|
0.83
|
|
56
|
Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease?
|
J Am Coll Cardiol
|
2006
|
0.83
|
|
57
|
Coronary artery calcium scoring using electron-beam computed tomography: where does this test fit into a clinical practice?
|
Rev Cardiovasc Med
|
2002
|
0.82
|
|
58
|
Nuclear cardiology will remain the "gatekeeper" over CT angiography.
|
J Nucl Cardiol
|
2007
|
0.82
|
|
59
|
Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging.
|
Circulation
|
2004
|
0.82
|
|
60
|
Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?
|
J Am Coll Cardiol
|
2005
|
0.82
|
|
61
|
Gated SPECT in assessment of regional and global left ventricular function: an update.
|
J Nucl Cardiol
|
2013
|
0.82
|
|
62
|
Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists.
|
Am Heart J
|
2011
|
0.80
|
|
63
|
Comparative roles of cardiac CT and nuclear cardiology in assessment of the patient with suspected coronary artery disease.
|
J Invasive Cardiol
|
2009
|
0.79
|
|
64
|
Association of left ventricular mechanical dyssynchrony with survival benefit from revascularization: a study of gated positron emission tomography in patients with ischemic LV dysfunction and narrow QRS.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.79
|
|
65
|
Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention?
|
Curr Cardiol Rep
|
2014
|
0.78
|
|
66
|
Appropriate test selection for single-photon emission computed tomography imaging: association with clinical risk, posttest management, and outcomes.
|
Am Heart J
|
2013
|
0.78
|
|
67
|
Myocardial perfusion imaging versus CT coronary angiography: when to use which?
|
J Nucl Med
|
2011
|
0.78
|
|
68
|
Coronary CT angiography and comparative effectiveness research prognostic value of atherosclerotic disease burden in appropriately indicated clinical examinations.
|
JACC Cardiovasc Imaging
|
2011
|
0.78
|
|
69
|
Assessing the prognostic value of cardiovascular imaging: a statistical exercise or a guide to clinical value and application?
|
Circulation
|
2009
|
0.77
|
|
70
|
MDCT is better than stress perfusion imaging for detecting CAD--Against.
|
Eur J Nucl Med Mol Imaging
|
2006
|
0.75
|
|
71
|
The art and science of predicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function.
|
J Am Coll Cardiol
|
2002
|
0.75
|
|
72
|
What should we expect in a prognosis study in 2012?
|
J Nucl Cardiol
|
2012
|
0.75
|
|
73
|
Reply: Concerning the Role of Gender Difference in Obesity Paradox in Patients With Heart Failure.
|
JACC Heart Fail
|
2016
|
0.75
|
|
74
|
Evaluating the clinical impact of cardiovascular imaging: is a risk-based stratification paradigm relevant?
|
J Am Coll Cardiol
|
2012
|
0.75
|
|
75
|
Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender.
|
Heart
|
2013
|
0.75
|
|
76
|
Demonstration of an ectopic mediastinal parathyroid adenoma on Tc-99m sestamibi myocardial perfusion scintigraphy.
|
J Nucl Cardiol
|
2006
|
0.75
|
|
77
|
Design, rationale, and populations of an international outcomes and utilization study of pharmacologic stress SPECT myocardial perfusion imaging in contemporary practice.
|
J Nucl Cardiol
|
2008
|
0.75
|
|
78
|
Importance of residual myocardial ischemia after intervention in the genesis of cardiovascular events among patients with chronic coronary artery disease.
|
Curr Cardiol Rep
|
2011
|
0.75
|
|
79
|
Treatment Nuances in Cardiac Sarcoidosis.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
80
|
18F-FDG Imaging of carotid arteries for identifying the vulnerable patient: are we at the beginning of the end?
|
J Nucl Med
|
2013
|
0.75
|
|
81
|
Role of nuclear cardiology in advancing cardiac surgery.
|
Semin Thorac Cardiovasc Surg
|
2004
|
0.75
|